Protein folding by the endoplasmic reticulum (ER) is physiologically critical; its disruption causes ER stress and augments disease. ER stress activates the unfolded protein response (UPR) to restore homeostasis. If stress persists, the UPR induces apoptotic cell death, but the mechanisms remain elusive. Here, we report that unmitigated ER stress promoted apoptosis through cell-autonomous, UPR-controlled activation of death receptor 5 (DR5). ER stressors induced DR5 transcription via the UPR mediator CHOP; however, the UPR sensor IRE1a transiently catalyzed DR5 mRNA decay, which allowed time for adaptation. Persistent ER stress built up intracellular DR5 protein, driving ligand-independent DR5 activation and apoptosis engagement via caspase-8. Thus, DR5 integrates opposing UPR signals to couple ER stress and apoptotic cell fate.
T he endoplasmic reticulum (ER) mediates folding and maturation of transmembrane and secreted proteins (1, 2) . Elevated physiological demand for protein folding can cause misfolded proteins to accumulate in the ER lumen-a condition called ER stress. The unfolded protein response (UPR) senses such stress and mediates cellular adaptation by expanding the ER's protein-folding capacity while decreasing its synthetic load. Protein kinase R (PKR)-like kinase (PERK) and inositol-requiring enzyme 1a (IRE1a) are two key metazoan UPR sensors (1, 2); residing in the ER membrane, each has a lumenal domain that detects misfolded polypeptides. PERK harbors a cytoplasmic kinase moiety that phosphorylates eukaryotic translationinitiation factor 2a (eIF2a). This suppresses general translation but promotes synthesis of preferred factors-including ATF4, which activates the UPR transcription factor CCAAT/enhancer-binding protein homologous protein (CHOP), among other genes. IRE1a has both kinase and endoribonuclease (RNase) cytoplasmic moieties (3). The kinase controls RNase activity, which mediates regulated IRE1a-dependent decay (RIDD) of ER-associated mRNAs (4) and generates the UPR transcription factor X-box binding protein 1 spliced (XBP1s). Certain pathological conditions can cause irresolvable ER stress (5), often leading to apoptotic cell death (1, 2, 6) . Two interconnected signaling cascades control apoptosis: the intrinsic, mitochondrial pathway, and the extrinsic, death-receptor pathway (7) . Each engages distinct proteases, called initiator caspases, to activate a common set of executioner caspases (8) . Unmitigated ER stress regulates the intrinsic pathway via several Bcl-2 family proteins (1, 2, 6, 9, 10). Furthermore, IRE1a cleaves specific micro-RNAs to derepress caspase-2 expression (11); however, caspase-2 may be dispensable for ER stress-induced apoptosis (12) , which leaves the underlying initiation mechanisms obscure.
Experiments with biological and pharmacological ER stressors revealed consistent activation of caspase-8, the pivotal initiator in the extrinsic pathway (8) (Fig. 1) . The bacterial AB5 subtilase cytotoxin SubAB induces pathophysiological ER stress by cleaving the chaperone BiP (13) . SubAB caused dose-dependent BiP depletion and ER stress, evident by CHOP and XBP1s up-regulation, in KMS11 multiple myeloma cells (Fig. 1A) . In keeping with data that PERK activity persists, whereas IRE1a activation is transient (14) , CHOP remained elevated, whereas XBP1s declined by 24 hours. SubAB also induced activation of caspase-8 and caspase-3 by 24 hours, evident by cleaved caspase and poly(ADP ribose) polymerase (PARP) products. SubAB substantially increased caspase-8 and caspase-3/7 enzymatic activity, and DNA fragmentation-an apoptotic hallmark ( fig. S1 , A to C). Brefeldin-A (BfA)-an inhibitor of ER-toGolgi trafficking-similarly induced ER stress, caspase activation, and apoptosis in SK-MES-1 lung carcinoma cells ( (10); however, caspase-8 and Bid processing occurred much earlier, which suggests that Bim might support later apoptotic signals. Thus, caspase-8 plays a pivotal role, whereas caspase-2 appears dispensable, during apoptosis induction by unmitigated ER stress. Upon binding of cognate extracellular ligands, the death receptors Fas, DR4, or DR5 nucleate a death-inducing signaling complex (DISC) at the plasma membrane, which activates caspase-8 via the adaptor Fas-associated death domain (FADD) (17) . Consistent with evidence that ER stress upregulates DR5 transcription (18) , quantitative reverse transcription polymerase chain reaction (QPCR) showed a two-to fourfold DR5 mRNA induction by Tg, BfA, SubAB, or the glycosylation inhibitor tunicamycin (Tm), with less impact on DR4, Fas, or TNFR1 (Fig. 2, A and B, and fig. S2 , A to C). ER stressors most often elevated both the long (DR5L) and short (DR5S) splice variants of DR5 (Fig. 2C and fig. S2 , D to H) (19) . Tg upregulated DR5 within 6 hours, in concert with CHOP and XBP1s induction, yet preceding caspase-8 processing (Fig. 2C and fig. S2D ). Furthermore, Tg induced a DR5-nucleated complex with FADD and caspase-8, harboring elevated caspase-8 activity, independent of Bax ( Fig. 2D and fig. S2 fig. S2 , P and Q). DR5 siRNA knockdown in different cell lines strongly inhibited caspase activation and apoptosis in response to various ER stressors (Fig. 2, E to H, and fig. S2 , R to X). Thus, DR5 is critical for caspase-8-mediated apoptotic engagement by unmitigated ER stress.
Remarkably, siRNA depletion of the sole DR5 ligand, Apo2L/TRAIL (apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand), had no impact on Tg-induced apoptosis in HCT116 or SK-MES-1 cells, unlike caspase-8 knockdown (Fig. 3A and fig. S3, A and B) . Moreover, neutralization of extracellular Apo2L/TRAIL by using soluble DR4-and DR5-Fc fusion proteins, which blocked exogenously added ligand, did not inhibit apoptosis activation by Tg or BfA (Fig. 3B and  fig. S3, C and D) . Thus, ER stress induces ligandindependent DR5 activation. DR5 was barely detectable by immunofluorescence in resting SK-MES-1 cells but showed higher abundance with the addition of Tg or BfA (Fig. 3C) . In Tgtreated cells, DR5 colocalized with the Golgi marker RACS1 but not the ER marker KDEL; however, in BfA-treated cells-which had minimal Golgi-DR5 did colocalize with KDEL ( Fig.  3D and fig. S3 , E and F). Despite massively elevating total DR5, BfA did not substantially upregulate cell surface DR5, nor did it increase sensitivity to exogenous Apo2L/TRAIL ( fig. S3 , G to J). However, Tg, which up-regulated both total and cell surface DR5, did enhance sensitivity to added ligand ( fig. S3, K to N) . DR5 partially colocalized with cleaved caspase-8 within Tg-treated cells ( fig. S3O ), which supports intracellular activation. Size-exclusion chromatography of detergent extracts from HCT116 cells revealed Tg-driven up-regulation of DR5L and DR5S in low molecular weight (MW) fractions-representing DR5 oligomers; elevated DR5L appeared also in high SCIENCE sciencemag.org MW fractions-which indicates the presence of DR5L multimers (Fig. 3E) . Caspase-8 activity occurred in two peaks: one coinciding with DR5L in high MW fractions, the other separate from DR5 in low MW compartments (Fig. 3F) . Chemical cross-linking verified Tg-induced formation of DR5 oligomers and multimers ( fig. S3P ). Furthermore, selective DR5L siRNA knockdown attenuated Tg-driven activation of caspase-8 and apoptosis ( fig. S3, Q to T) . Thus, Tg up-regulates both DR5 variants but DR5L preferentially multimerizes, recruiting and activating caspase-8 and releasing processed enzyme into lower MW fractions. Consistent with earlier evidence (18, 20) , siRNA depletion of CHOP substantially blocked DR5 mRNA up-regulation by Tg or BfA, whereas knockdown of the CHOP transcriptional targets ER oxidase 1a (ERO1a) or growth arrest and DNA damage-inducible 34 (GADD34) did not (Fig. 4A and fig. S4 , A to E); these findings support direct CHOP control of DR5 mRNA. Although GADD34 dephosphorylates eIF2a to reinitiate translation, ERO1a is important for protein disulfide isomerization and folding in the ER lumen (6) . ERO1a knockdown did inhibit DR5L protein up-regulation and the associated apoptotic events ( fig. S4, F to H) , which suggests that ERO1a may facilitate folding of DR5L (DR5L harbors more cysteine residues than DR5S). In contrast to CHOP depletion, siRNA knockdown of IRE1a attenuated DR5 mRNA decay in Tg-treated cells (Fig. 4B and  fig. S4, I to L), which suggests that IRE1a counter- acts apoptosis by mediating DR5 RIDD. Indeed, a recombinant protein comprising IRE1a's catalytic domains cleaved in vitro transcribed DR5 mRNAs at discrete sites, and this was blocked by the IRE1a RNase inhibitor 4m8C (21) (Fig. 4C and fig. S4M ). Furthermore, whereas CHOP siRNA attenuated Tg-induced DR5 up-regulation, caspase-8 activation, and apoptosis, IRE1a depletion augmented these events (Fig. 4, D and E, and fig. S4N ). Conversely, XBP1s knockdown-which led to compensatory IRE1a hyperphosphorylation (Fig. 4D) as reported (22)-accelerated DR5 mRNA decay and diminished DR5 up-regulation, caspase-8 activation, and apoptosis (Fig. 4, B, D, and E, and fig.  S4 , J to L and N). Finally, 4m8C enhanced caspase activation by Tg (Fig. 4F and fig. S4O ), which confirms an antiapoptotic role for IRE1a RNase. Thus, CHOP and RIDD exert opposing effects on DR5 to control caspase-8 activation and apoptosis.
Our data delineate a cell-autonomous mechanism wherein DR5 integrates dynamic UPR signals to control apoptosis in relation to ER stress ( fig. S4P ). Upon reversible ER disruption, PERK-CHOP activity induces, whereas RIDD suppresses, DR5 transcripts. If ER stress resolves, UPR activity subsides, and DR5 mRNA returns to baseline. However, if ER stress prevails, PERK-CHOP function persists, whereas IRE1a activity attenuates (14) , which permits DR5 mRNA to rise. DR5 accumulation in the ER and Golgi apparatus drives ligand-independent multimerization of DR5L, which-consistent with earlier data (23)-has greater propensity to cluster than DR5S. ERO1a, previously implicated in UPR-driven apoptosis (6), facilitates DR5L up-regulation, perhaps by supporting disulfide isomerization. DR5L provides a DISC-like intracellular platform for caspase-8 recruitment and apoptosis initiation. It was proposed that ER stress augments apoptosis by increasing autocrine death-ligand signaling (18, 24, 25) ; however, ER disruption would attenuate ligand secretion. Our data reveal that DR5 acts as an intracellular "gauge" for persistence of ER stress. Opposing controls on DR5 mRNA synthesis and decay by PERK-CHOP versus IRE1a define a time window for adaptation, before committing the cell to an apoptotic fate.
